QNTM
Quantum Biopharma
$2.97
−$0.02 (−0.67%)Jul 27, 2026
Key metrics
The numbers that frame QNTM today
- Market cap
- $11.55M
- P/E (TTM)
- -0.5
- EV / FCF
- -1.2
- ROIC
- 2,182.6%
- Div yield
- 0%
- Debt / equity
- 1.5
- 52wk Low
- $2.07
- 52wk High
- $31.91
Growth
Revenue and earnings trend for QNTM
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about QNTM
Is Quantum Biopharma a good buy?
No. Quantum Biopharma has poor quality and poor momentum. Both signals point to a weaker setup. Growth looks poor. That could put pressure on the long-term business case. We think Quantum Biopharma is selling at a very high price.
What is the market capitalization of QNTM?
Quantum Biopharma's market capitalization is $11.55M.
What is the P/E ratio for QNTM stock?
Quantum Biopharma's current P/E ratio is -0.5.
What is the 52-week high for QNTM stock?
The 52-week high for Quantum Biopharma is $31.91. The current close of $2.97 is 90.7% below that high.
What is the 52-week low for QNTM stock?
The 52-week low for Quantum Biopharma is $2.07. The current close of $2.97 is 43.5% above that low.
Does QNTM stock pay dividends?
Quantum Biopharma does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for QNTM?
Quantum Biopharma's Debt / Equity ratio is 1.46.